Ways to Battle the $431 Billion Fake Pharmaceutical Industry

Review of Business & Finance Studies, V. 8 (1), p. 33-40

8 Pages Posted: 13 Nov 2017

See all articles by Brian Gurney

Brian Gurney

Montana State University - Billings

Gary Amundson

Montana State University - Billings

Salem Lotfi Boumediene

Montana State University - Billings

Date Written: 2017

Abstract

Nowadays, counterfeit drugs are available in the marketplace more than ever. One has no idea whether they are acquiring the genuine drug or not. Many deaths have occurred because of mistakes made by consuming counterfeit medication. Not only does it alter one’s health but it also crushes their hopes. The data concerning counterfeit drugs are increasingly being published in reports and reviews. It seems like government does not care about the issue since it is ongoing and growing. Governments seem to underestimate the importance of the issue, hence its growing prospect. Harsher sanctions are needed to prove that counterfeiting is not an unpunished crime. Whoever commits that felony has to face the consequences that come along with breaking the law and possibly participating in harming and endangering one’s life.

Keywords: Medicine, Counterfeit Drugs, Generic, Regulation

JEL Classification: I10, I18, I19, K20, K42, F19, F23

Suggested Citation

Gurney, Brian and Amundson, Gary and Boumediene, Salem Lotfi, Ways to Battle the $431 Billion Fake Pharmaceutical Industry (2017). Review of Business & Finance Studies, V. 8 (1), p. 33-40. Available at SSRN: https://ssrn.com/abstract=3028256

Brian Gurney (Contact Author)

Montana State University - Billings ( email )

1500 University Dr
Billings, MT 59101
United States

Gary Amundson

Montana State University - Billings ( email )

1500 University Dr
Billings, MT 59101
United States

Salem Lotfi Boumediene

Montana State University - Billings ( email )

Register to save articles to
your library

Register

Paper statistics

Downloads
58
rank
350,508
Abstract Views
242
PlumX Metrics